Colchicine Levels in the Serum of FMF (Familial Mediterranean Fever) Patients

Last updated: April 18, 2018
Sponsor: Sheba Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT03210610
3997-17-SMC
  • Ages > 18
  • All Genders

Study Summary

in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • constant colchicine levels

Study Design

Total Participants: 80
Study Start date:
October 19, 2017
Estimated Completion Date:
July 15, 2020

Study Description

80 FMF patients will enroll: 20 taking 1 mg colchicine a day 20 taking 1.5 mg colchicine a day 20 taking 2 mg colchicine a day 20 taking 2.5 mg colchicine a day one blood sample for trough colchicine levels will be taken. response to treatment, colchicine side effects and anthropometric data will be collected.

Connect with a study center

  • Sheba Medical Center

    Ramat Gan,
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.